96 related articles for article (PubMed ID: 21240152)
1. Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.
Saatcioglu O; Gumus S; Kamberyan K; Yanik M
Psychopharmacol Bull; 2010; 43(4):70-2. PubMed ID: 21240152
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
[TBL] [Abstract][Full Text] [Related]
5. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
6. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
Coley KC; Scipio TM; Ruby C; Lenze EJ; Fabian TJ
J Psychiatr Pract; 2009 Mar; 15(2):150-3. PubMed ID: 19339850
[TBL] [Abstract][Full Text] [Related]
7. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of aripiprazole on patients with at-risk mental state and subjective well-being].
Kobayashi T
Seishin Shinkeigaku Zasshi; 2010; 112(11):1156-63. PubMed ID: 21351695
[No Abstract] [Full Text] [Related]
9. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
10. Role of aripiprazole in treating mood disorders.
García-Amador M; Pacchiarotti I; Valentí M; Sanchez RF; Goikolea JM; Vieta E
Expert Rev Neurother; 2006 Dec; 6(12):1777-83. PubMed ID: 17181424
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
12. Current evidence for aripiprazole as augmentation therapy in major depressive disorder.
Khan A
Expert Rev Neurother; 2008 Oct; 8(10):1435-47. PubMed ID: 18928339
[TBL] [Abstract][Full Text] [Related]
13. Efficacy with high-dose aripiprazole after olanzapine-related metabolic disturbances.
Chavez B; Poveda RA
Ann Pharmacother; 2006 Dec; 40(12):2265-8. PubMed ID: 17119107
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole plus topiramate in opioid-dependent patients with schizoaffective disorder: an 8-week, open-label, uncontrolled, preliminary study.
Bruno A; Romeo VM; Pandolfo G; Scimeca G; Zoccali RA; Muscatello MR
Subst Abus; 2014; 35(2):119-21. PubMed ID: 24821345
[TBL] [Abstract][Full Text] [Related]
15. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
[TBL] [Abstract][Full Text] [Related]
16. Supersensitivity psychosis after tapering aripiprazole: a case report.
Chang CC; Hsu WY; Chen SH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):388-9. PubMed ID: 19166895
[No Abstract] [Full Text] [Related]
17. [Present data and treatment schedule of aripiprazole in the treatment of schizophrenia].
Limosin F; Azorin JM; Krebs MO; Millet B; Glikman J; Camus V; Crocq MA; Costentin J; Daléry J
Encephale; 2008 Jan; 34(1):82-92. PubMed ID: 18514155
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive aripiprazole in treatment-resistant bipolar depression.
Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole: new drug. Just another neuroleptic.
Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
